MedTrace Logo

Obstructive Sleep Apnea Patients Treated With Mandibular Advancement Device

NCT05621577 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2023-02-08

No results posted yet for this study

Summary

The purpose of this study is to evaluate efficacy of mandibular advancement device (MAD). on treating obstructive sleep apneas, symptoms, Apnea/Hypopnea Index (QHI) and the Respiratory Arousal Index (AHI/REI) and peripheral capillary oxygen saturation (SpO2) Range, PULSE in patients with mild to moderate obstructive sleep apnea/hypopnea syndrome, and evaluating potential dental side effects

Conditions

  • Sleep Apnea, Obstructive

Interventions

DEVICE

MANDIBULAR ADVANCEMENT DEVICE

orthodontically treating obstructive sleep apnea

Sponsors & Collaborators

  • Hawler Medical University

    lead OTHER

Principal Investigators

  • Zana Omer, Assist.Prof · Hawler Medical University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
25 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-05
Primary Completion
2023-07-01
Completion
2023-08-01

Countries

  • Iraq

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05621577 on ClinicalTrials.gov